QNB CORP.·4

Feb 18, 2:52 PM ET

Lehocky Jeffrey 4

4 · QNB CORP. · Filed Feb 18, 2026

Research Summary

AI-generated summary of this filing

Updated

QNB Corp (QNBC) CFO Jeffrey Lehocky Receives Restricted Stock Award

What Happened Jeffrey Lehocky, Chief Financial Officer of QNB Corp. (QNBC), received restricted stock awards on February 13, 2026. The filing shows four acquisitions: 750 shares at $38.00 each (value $28,500) plus three derivative awards of 250 shares each at $38.00 (each valued $9,500), for a total of 1,500 shares valued at $57,000. These were awards/grants (compensation), not open‑market purchases or sales.

Key Details

  • Transaction date: 2026-02-13; reported on Form 4 filed 2026-02-18.
  • Price per share: $38.00.
  • Items reported: 750 shares acquired (direct) = $28,500; 3 derivative awards × 250 shares = 750 derivative shares = $28,500; total 1,500 shares = $57,000.
  • Footnote: F1 indicates these are Restricted Stock Awards. The derivative entries reflect award of restricted/derivative securities (e.g., RSAs/RSUs).
  • Shares owned after transaction: not disclosed in the provided excerpt of the filing.
  • Filing timeliness: the Form 4 was submitted five days after the transaction date; Form 4s are typically due within two business days, so this filing may be later than the standard reporting window.

Context This was a compensation grant to the CFO (restricted stock), which is common and generally reflects executive compensation rather than an immediate market sentiment signal. Restricted awards typically vest over time; check the full Form 4 or company filings for vesting terms and for any subsequent sales or disclosures.

Insider Transaction Report

Form 4
Period: 2026-02-13
Lehocky Jeffrey
EVP, Chief Financial Officer
Transactions
  • Award

    Common Stock

    [F1]
    2026-02-13$38.00/sh+750$28,5005,151.966 total
  • Award

    Performance-based restricted stock award

    2026-02-13$38.00/sh+250$9,500250 total
    Exercise: $0.00From: 2026-02-13Exp: 2036-02-13Common Stock (250 underlying)
  • Award

    Performance-based restricted stock award

    2026-02-13$38.00/sh+250$9,500250 total
    Exercise: $0.00From: 2027-02-13Exp: 2036-02-13Common Stock (250 underlying)
  • Award

    Performance-based restricted stock award

    2026-02-13$38.00/sh+250$9,500250 total
    Exercise: $0.00From: 2028-02-13Exp: 2036-02-13Common Stock (250 underlying)
Holdings
  • Common Stock(Right to Buy)

    Exercise: $29.51From: 2024-02-15Exp: 2033-02-15Common Stock (160 underlying)
    160
  • Common Stock(Right to Buy)

    Exercise: $29.51From: 2025-02-15Exp: 2033-02-15Common Stock (160 underlying)
    160
  • Common Stock(Right to Buy)

    Exercise: $29.51From: 2026-02-15Exp: 2033-02-15Common Stock (160 underlying)
    160
  • Common Stock(Right to Buy)

    Exercise: $29.51From: 2027-02-15Exp: 2033-02-15Common Stock (160 underlying)
    160
  • Common Stock(Right to Buy)

    Exercise: $29.51From: 2028-02-15Exp: 2033-02-15Common Stock (160 underlying)
    160
  • Common Stock(Right to Buy)

    Exercise: $23.40From: 2025-02-15Exp: 2034-02-15Common Stock (600 underlying)
    600
  • Common Stock(Right to Buy)

    Exercise: $23.40From: 2026-02-15Exp: 2034-02-15Common Stock (600 underlying)
    600
  • Common Stock(Right to Buy)

    Exercise: $23.40From: 2027-02-15Exp: 2034-02-15Common Stock (600 underlying)
    600
  • Common Stock(Right to Buy)

    Exercise: $23.40From: 2028-02-15Exp: 2034-02-15Common Stock (600 underlying)
    600
  • Common Stock(Right to Buy)

    Exercise: $23.40From: 2029-02-15Exp: 2034-02-15Common Stock (600 underlying)
    600
  • Common Stock(Right to Buy)

    Exercise: $33.50From: 2026-02-14Exp: 2035-02-14Common Stock (860 underlying)
    860
  • Common Stock(Right to Buy)

    Exercise: $33.50From: 2027-02-14Exp: 2035-02-14Common Stock (860 underlying)
    860
  • Common Stock(Right to Buy)

    Exercise: $33.50From: 2028-02-14Exp: 2035-02-14Common Stock (860 underlying)
    860
  • Common Stock(Right to Buy)

    Exercise: $33.50From: 2029-02-14Exp: 2035-02-14Common Stock (860 underlying)
    860
  • Common Stock(Right to Buy)

    Exercise: $33.50From: 2030-02-14Exp: 2035-02-14Common Stock (860 underlying)
    860
Footnotes (1)
  • [F1]Restricted Stock Award
Signature
Jeffrey Lehocky|2026-02-13

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT